Real-time financial, economic, and global news with market-focused context and analysis.
Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.
Palantir Technologies' Chief Technology Officer and Executive Vice President, Sankar Shyam, sold $22.5 million of Class A Common Stock on February 20, 2026, in several transactions. The same day he converted a large block of Class B shares to Class A and received restricted stock units upon vesting. The stock has been under pressure year-to-date, w…
Ryan D. Taylor, an officer at Palantir Technologies Inc (NYSE: PLTR), sold 20,338 Class A shares on February 20, 2026, receiving $2.67 million in proceeds. The disposition was filed on a Form 4 with the SEC and occurred while the stock trades down 27.5% year-to-date and around $128.82 per share. The company has announced a partnership with Rackspac…
UBS analysts have increased their exposure to a basket of Chinese technology companies following a recent selloff in the sector. The bank points to healthy earnings, attractive valuations and expected acceleration in capital expenditure and AI development in 2026 as the drivers for potential returns. UBS adjusted portfolio weightings across large a…
ImmunityBio director Christobel Selecky sold 25,000 shares on February 23, 2026, for $10 apiece, generating $250,000. On the same day she exercised options to buy 25,000 shares at $2.98, a transaction worth $74,500. The sale was carried out under a Rule 10b5-1 plan. The company has reported substantial revenue growth for its cancer therapy ANKTIVA,…
Palantir Technologies CEO Alexander C. Karp sold $65.9 million worth of Class A common stock in a series of transactions on February 20, 2026, and completed several conversions of Class B shares to Class A. The stock is trading below the sales range and is viewed by one service as overvalued versus Fair Value, even as analysts upgraded the shares a…
Palantir Technologies director Stephen Andrew Cohen sold $43.7 million of Class A Common Stock on February 20, 2026 across a series of transactions. The company’s shares have fallen 27.5% year-to-date and trade at a high price-to-earnings multiple. Cohen also converted Class B shares to Class A and restricted stock units were exercised into Class B…
Barry J. Simon, a director at ImmunityBio, sold 175,000 shares of the company’s common stock in late February 2026 for roughly $1.78 million under a pre-arranged Rule 10b5-1 plan. The transactions occurred as the stock traded above its 52-week high amid substantial revenue growth for the company’s cancer therapy ANKTIVA and new distribution deals i…
KalVista Pharmaceuticals CFO Brian Piekos sold 1,767 shares on February 23, 2026, netting $27,506 at a weighted average price of $15.5668 per share. Earlier in the week he exercised options on 5,000 shares and converted 5,000 restricted stock units into common stock. The insider moves come as KalVista reports preliminary fourth-quarter 2025 revenue…
KalVista Pharmaceuticals Chief Medical Officer Paul K. Audhya sold 5,354 shares on February 23, 2026, generating about $83,344. The sale followed the exercise and conversion of 11,250 restricted stock units into common shares on February 21 and 22. KalVista's stock trades around $15.77, and the company reported preliminary global EKTERLY sales of r…
Nicole Sweeny, chief commercial officer of KalVista Pharmaceuticals (KALV), sold 3,975 shares of common stock on February 23, 2026, to satisfy tax-withholding tied to vested RSUs. The sale totaled about $61,878 at a weighted average price of $15.5668. The company reported preliminary fourth-quarter 2025 EKTERLY revenue of roughly $35 million, well …
Fortescue reported a stronger first-half performance driven by a record shipment run and improved realised hematite prices. The miner posted underlying EBITDA of $4.5 billion and net profit after tax of $1.9 billion for the six months to Dec. 31, each up 23% year-on-year, and declared a higher fully franked interim dividend while maintaining full-y…
Christopher Yea, Chief Development Officer at KalVista Pharmaceuticals (KALV), sold 4,347 shares on February 23, 2026, to satisfy tax-withholding obligations stemming from the vesting and settlement of restricted stock units. The transaction was non-discretionary, according to a Form 4 filing. Separately, KalVista reported roughly $35 million in gl…
KalVista Pharmaceuticals Chief Executive Officer Benjamin L. Palleiko sold 10,034 shares on February 23, 2026 to cover tax withholding obligations, realizing roughly $156,197. The company reported about $35 million in fourth-quarter 2025 revenue from its oral HAE treatment EKTERLY, contributing to approximately $49 million in full-year sales after …
Australia's consumer prices rose more than expected in January, driven by higher housing and health expenses. The trimmed mean core inflation measure climbed, recording its quickest annual rise since late 2024 and prompting markets to shorten the odds of another interest-rate hike in the near term, including May.
Reddit Chief Operating Officer Jennifer L. Wong sold a combined $5.6 million of Class A Common Stock on February 24, 2026, through a series of transactions executed at prices between $141.82 and $147.47. The divestiture included shares sold directly and via the MorMa Trust, and followed a company withholding of shares to cover tax obligations. The …
Warner Bros Discovery said Paramount Skydance’s amended proposal could be reasonably viewed as a superior bid, triggering a potential four-day matching window for Netflix on terms to acquire the studio and streaming operations that include HBO Max and the Harry Potter franchise. The two all-cash proposals differ across headline price, financing bac…
Reddit Chief Technology Officer Christopher Brian Slowe sold $2.74 million worth of Class A Common Stock on February 23 in a series of transactions that followed option exercises and a recent award of shares. The insider activity coincides with robust fourth-quarter 2025 financial results for Reddit and comes against a backdrop of regulatory penalt…
U.S. stock futures showed little movement Tuesday evening as markets awaited Nvidia's quarterly results and a State of the Union address by President Donald Trump. Futures stabilized following a positive trading day for equities, while several after-hours movers reflected company-specific news and guidance. The political backdrop included a revised…
Michael Warren Vostrizansky, a director at Neptune Insurance Holdings Inc (NP), purchased 23,000 shares of Class A Common Stock on February 20, 2026, investing $494,414. The buy occurred as the stock trades below the purchase price and following a wave of analyst upgrades spurred by better-than-expected fourth-quarter adjusted EBITDA and revised re…
Japan's services producer price index rose 2.6% year-on-year in January, unchanged from December, with higher charges for construction and temporary staff services cited as principal drivers. The Bank of Japan has wound down its massive stimulus program and raised short-term rates to 0.75%, and officials say they are prepared to lift borrowing cost…
Nucor (NUE) is an investable way to play a steel reflation with downside protection. The stock sits near $175 after tariff-driven swings; fundamentals point to resiliency: $40.1B market cap, EPS of $7.20, P/E ~24.9, debt/equity 0.33. Trade plan: enter $175.19, stop $165.00, target $197.00 over a medium-to-long holding period while monitoring tariff…
The White House has scheduled a meeting to review President Trump's plan to remake Washington Dulles International Airport, following his public criticism of the facility's design. Transportation Secretary Sean Duffy is expected to participate. The airport has recently recorded strong passenger growth, and federal officials have solicited proposals…
WiseTech Global reported a robust first half with revenue lifted by the e2open acquisition, delivered double-digit EBITDA growth, and confirmed full-year targets while outlining plans to remove as many as 2,000 jobs through an AI-driven efficiency program that includes up to a 50% reduction in product development and customer service roles over FY2…
PayPal spiked on buyout whispers, but the company’s real problems — slowing growth, leadership turnover and pending litigation — make a strategic buyout unlikely and the rally unsustainable. This trade idea proposes a mid-term short to capture mean reversion as the market re-prices execution risk away from takeover speculation.
Woolworths Ltd reported a 16.4% increase in underlying net profit after tax for the six months to January 4, alongside modest sales and margin gains. Shares jumped at the open as management flagged improving consumer demand, though statutory net profit fell sharply after a substantial provision for legal costs related to historical underpayments.
